High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply

Lancet. 2024 Apr 6;403(10434):1339-1340. doi: 10.1016/S0140-6736(23)02879-9.

Authors

Leon Peto¹, Buddha Basnyat², Peter Horby³

Affiliations

¹ Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK. Electronic address: leon.peto@ndph.ox.ac.uk.
² Patan Academy of Health Sciences, Lalitpur, Nepal.
³ Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, UK.

PMID: 38582564
DOI: 10.1016/S0140-6736(23)02879-9

No abstract available

Publication types

Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use
COVID-19*
Humans

Substances

Adrenal Cortex Hormones